IPHA_logo_main_version_h100IPHA_logo_main_version_h100IPHA_logo_main_version_h100IPHA_logo_main_version_h100
  • Home
  • #InnovateForLife
  • News
  • Events
    • IPHA Forum
    • IPHA Conference
    • All other events
  • Publications
    • 2025
      • EFPIA Patients Wait Indicator 2024
      • IPHA Position Paper on Fairer and Faster Access to Medicine
    • 2024
      • EFPIA Patient WAIT Indicator Survey
      • Clinical Trials Agreement
      • IPHA Clinical Trials Activity Comparison Report
      • Making Ireland a European Leader in Clinical Research
    • 2023
      • Achieving Universal Access to New Medicines for Irish Patients
      • Oireachtas briefing
      • IPHA Policy on Supply Outside Reimbursement Final
      • IPHA Self-Care Infographic
    • 2022
      • IPHA reimbursement timelines analysis 2022
      • Factors Affecting the Location of Biopharmaceutical Investments and Implications for European Policy Priorities
      • IHE Cancer Care Comparator Study
      • White Paper on Enterprise
    • 2021
      • Clinical Trials Survey
      • Cell and Gene Pathfinder Study
      • IPHA Codes of Practice
      • Agreement 2021
    • Pre 2020
      • BioPharma Ambition
      • Manifesto for Better Health
      • Innovation and the IP Framework
      • Self-Care: Taking Charge of Your Health
      • Vaccines For Life
      • Perspectives on Ireland’s Medicines Future
  • Code
    • Codes of Practice
    • Transfers of Value
    • Mandatory notification regarding Advisory Board Meetings
    • IPHA Code Training
    • Complaints
  • Clinical & Regulatory
    • Regulation for Innovation
    • Clinical Trials
    • Medicine Safety
    • Regulatory Science Ireland
    • Counterfeit Medicines
  • Self-Care
  • About
    • Members
    • Board of Directors
    • Media Queries
    • Our Team
    • Affiliates Programme
    • Job Opportunities
  • Home
  • #InnovateForLife
  • News
  • Events
    • IPHA Forum
    • IPHA Conference
    • All other events
  • Publications
    • 2025
      • EFPIA Patients Wait Indicator 2024
      • IPHA Position Paper on Fairer and Faster Access to Medicine
    • 2024
      • EFPIA Patient WAIT Indicator Survey
      • Clinical Trials Agreement
      • IPHA Clinical Trials Activity Comparison Report
      • Making Ireland a European Leader in Clinical Research
    • 2023
      • Achieving Universal Access to New Medicines for Irish Patients
      • Oireachtas briefing
      • IPHA Policy on Supply Outside Reimbursement Final
      • IPHA Self-Care Infographic
    • 2022
      • IPHA reimbursement timelines analysis 2022
      • Factors Affecting the Location of Biopharmaceutical Investments and Implications for European Policy Priorities
      • IHE Cancer Care Comparator Study
      • White Paper on Enterprise
    • 2021
      • Clinical Trials Survey
      • Cell and Gene Pathfinder Study
      • IPHA Codes of Practice
      • Agreement 2021
    • Pre 2020
      • BioPharma Ambition
      • Manifesto for Better Health
      • Innovation and the IP Framework
      • Self-Care: Taking Charge of Your Health
      • Vaccines For Life
      • Perspectives on Ireland’s Medicines Future
  • Code
    • Codes of Practice
    • Transfers of Value
    • Mandatory notification regarding Advisory Board Meetings
    • IPHA Code Training
    • Complaints
  • Clinical & Regulatory
    • Regulation for Innovation
    • Clinical Trials
    • Medicine Safety
    • Regulatory Science Ireland
    • Counterfeit Medicines
  • Self-Care
  • About
    • Members
    • Board of Directors
    • Media Queries
    • Our Team
    • Affiliates Programme
    • Job Opportunities
  • Home
  • About Us
  • Contact Us

2025 Innovate for Life campaign

  • Home
  • IPHA News
  • Featured
  • 2025 Innovate for Life campaign
October 22, 2025

IPHA launches its 2025 Innovate for Life campaign, championing the power of prevention to create healthier, happier lives.

Share

Related posts

July 23, 2025

Practicing more Self-Care has the potential to ease the GP crisis by freeing up one working hour per GP per day


More
May 7, 2025

Ireland has the lowest rate of availability for new cancer medicines in Western Europe, limiting treatment options for patients.


More
February 26, 2025

New research finds that patients in Ireland could get access to medicines one year earlier


More

Terms and Conditions    |    Privacy Statement   |   Sitemap    |    Cookies


Registered Number: 254776    |    Registered Address: 7 Clanwilliam Terrace, Dublin 2, D02 CC64 Ireland   |  Email: info@ipha.ie

© 2024 IPHA